Are there next-generation GLP-1 RAs in development? How are they similar and how might they differ from currently available agents? Dosing-wise? Efficacy? Side effects? Weight loss?

Are there next-generation GLP-1 RAs in development? How are they similar and how might they differ from currently available agents? Dosing-wise? Efficacy? Side effects? Weight loss?

Are there next-generation GLP-1 RAs in development? How are they similar and how might they differ from currently available agents? Dosing-wise? Efficacy? Side effects? Weight loss?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Luc Van Gaal, MD

Luc Van Gaal, MD

Professor of Medicine
Department of Endocrinology, Diabetology and Metabolism
Antwerp University Hospital
Antwerp, Belgium